Population
55 women with angiosarcoma of the breast treated between 1990 and 2003
Design
Cohort
Follow-up
median 3.7 years
Authors
Discussion
Loading...
Member takes
Implication
Tumor recurrence identifies high-risk breast angiosarcoma patients; leaves open whether radiation history should influence surveillance or therapy.
Structured PICO
P
Population
55 women with angiosarcoma of the breast treated between 1990 and 2003
O
Outcome
Overall survival (OS) and disease-free survival (DFS)hard clinical
In a cohort of 55 women with breast angiosarcoma, radiation-naive and radiation-associated tumors behaved similarly, with tumor recurrence being the only significant adverse prognostic factor for overall survival.
Cite This Study
Vorburger et al. (2005) studied this question.